Huang J, Li A, Liang R, Wu X, Jia S, Chen J
Biomater Transl. 2025; 5(4):425-443.
PMID: 39872930
PMC: 11764185.
DOI: 10.12336/biomatertransl.2024.04.007.
Yu Y, Cao J, Liu R, Zhou M, Wei J, Zheng H
Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(11):2227-2234.
PMID: 39623279
PMC: 11605208.
DOI: 10.12122/j.issn.1673-4254.2024.11.20.
Subbiahanadar Chelladurai K, Selvan Christyraj J, Rajagopalan K, Vadivelu K, Chandrasekar M, Das P
J Artif Organs. 2024; .
PMID: 39592544
DOI: 10.1007/s10047-024-01478-4.
Zhang Y, Liu K, He H, Xiao H, Fang Z, Chen X
Environ Sci Pollut Res Int. 2024; 31(11):16256-16273.
PMID: 38342830
DOI: 10.1007/s11356-024-32256-7.
Xue W, Wang T, Yao J, Wu W, Chen D, Yan B
Bioeng Transl Med. 2023; 8(6):e10586.
PMID: 38023722
PMC: 10658544.
DOI: 10.1002/btm2.10586.
Development of glioblastoma organoids and their applications in personalized therapy.
Xu C, Yuan X, Hou P, Li Z, Wang C, Fang C
Cancer Biol Med. 2023; 20(5).
PMID: 37283493
PMC: 10246443.
DOI: 10.20892/j.issn.2095-3941.2023.0061.
Beijing Children's Hospital guidelines on the design and conduction of the first standardized database for medulloblastoma.
Yang W, Ma W, Huang J, Cai Y, Peng X, Zhao F
Metab Brain Dis. 2023; 38(7):2393-2400.
PMID: 37261631
DOI: 10.1007/s11011-023-01233-3.
Targeted therapy for head and neck cancer: signaling pathways and clinical studies.
Li Q, Tie Y, Alu A, Ma X, Shi H
Signal Transduct Target Ther. 2023; 8(1):31.
PMID: 36646686
PMC: 9842704.
DOI: 10.1038/s41392-022-01297-0.
A novel deep learning segmentation model for organoid-based drug screening.
Wang X, Wu C, Zhang S, Yu P, Li L, Guo C
Front Pharmacol. 2023; 13:1080273.
PMID: 36588731
PMC: 9794595.
DOI: 10.3389/fphar.2022.1080273.
Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities.
Chen J, Na F
Front Bioeng Biotechnol. 2022; 10:1066869.
PMID: 36568297
PMC: 9772457.
DOI: 10.3389/fbioe.2022.1066869.
Advancing intestinal organoid technology to decipher nano-intestine interactions and treat intestinal disease.
Bao L, Cui X, Bai R, Chen C
Nano Res. 2022; 16(3):3976-3990.
PMID: 36465523
PMC: 9685037.
DOI: 10.1007/s12274-022-5150-4.
Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma.
Wang M, Zhou Z, Wang X, Zhang C, Jiang X
Cell Death Dis. 2022; 13(7):588.
PMID: 35803912
PMC: 9270460.
DOI: 10.1038/s41419-022-05041-y.
Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model.
Hampel H, Caruso G, Nistico R, Piccioni G, Mercuri N, Giorgi F
Curr Neuropharmacol. 2021; 21(1):31-53.
PMID: 34852743
PMC: 10193755.
DOI: 10.2174/1570159X19666211201095701.
Editorial: Precision Medicine in Chronic Inflammation.
Distler O, Ludwig R, Niemann S, Riemekasten G, Schreiber S
Front Immunol. 2021; 12:770462.
PMID: 34630441
PMC: 8495129.
DOI: 10.3389/fimmu.2021.770462.
Developments and Opportunities for 3D Bioprinted Organoids.
Ren Y, Yang X, Ma Z, Sun X, Zhang Y, Li W
Int J Bioprint. 2021; 7(3):364.
PMID: 34286150
PMC: 8287496.
DOI: 10.18063/ijb.v7i3.364.
Tumor-treating fields (TTFields)-based cocktail therapy: a novel blueprint for glioblastoma treatment.
Wang M, Zhang C, Wang X, Yu H, Zhang H, Xu J
Am J Cancer Res. 2021; 11(4):1069-1086.
PMID: 33948346
PMC: 8085847.
Precision oncology in metastatic colorectal cancer - from biology to medicine.
Di Nicolantonio F, Vitiello P, Marsoni S, Siena S, Tabernero J, Trusolino L
Nat Rev Clin Oncol. 2021; 18(8):506-525.
PMID: 33864051
DOI: 10.1038/s41571-021-00495-z.
Recent advances in preclinical models for lung squamous cell carcinoma.
Pan Y, Han H, Labbe K, Zhang H, Wong K
Oncogene. 2021; 40(16):2817-2829.
PMID: 33707749
DOI: 10.1038/s41388-021-01723-7.
Patient-Specific Retinal Organoids Recapitulate Disease Features of Late-Onset Retinitis Pigmentosa.
Gao M, Lei X, Han F, He K, Jin S, Zhang Y
Front Cell Dev Biol. 2020; 8:128.
PMID: 32211407
PMC: 7068133.
DOI: 10.3389/fcell.2020.00128.
